Sphera Funds Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.01M | Buy |
394,693
+159,859
| +68% | +$1.62M | 0.94% | 34 |
|
|
2025
Q1 | $1.31M | Sell |
234,834
-38,379
| -14% | -$214K | 0.3% | 80 |
|
|
2024
Q4 | $2.2M | Buy |
273,213
+144,817
| +113% | +$1.17M | 0.4% | 77 |
|
|
2024
Q3 | $1.32M | Buy |
+128,396
| New | +$1.32M | 0.21% | 92 |
|
|
2024
Q1 | – | Sell |
-126,800
| Closed | -$1.17M | – | 104 |
|
|
2023
Q4 | $1.17M | Buy |
+126,800
| New | +$1.17M | 0.19% | 75 |
|
|
2021
Q2 | – | Sell |
-169,900
| Closed | -$4.16M | – | 151 |
|
|
2021
Q1 | $4.16M | Sell |
169,900
-12,300
| -7% | -$301K | 0.32% | 69 |
|
|
2020
Q4 | $6.17M | Buy |
+182,200
| New | +$6.17M | 0.55% | 50 |
|